Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 17, 2023 09:01 ET | Source: CMI

Hemoglobinopathy Market to Surpass US$ 950.6 Million by 2030, Says Coherent Market Insights (CMI)

Burlingame, May 17, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global Hemoglobinopathy Market is estimated to be valued at US$ 636.9 million in 2023 and is expected to exhibit a...
November 16, 2021 07:00 ET | Source: Imara, Inc.

Imara Announces Interim Analysis Data from Forte Phase 2b Clinical Trial of Tovinontrine (IMR-687) in Transfusion-Dependent Subjects with Beta-thalassemia

Positive trend observed in transfusion-dependent subjects treated with higher dose tovinontrine for reduced transfusion burden Tovinontrine was generally well-tolerated in this patient population ...
June 11, 2021 03:00 ET | Source: Imara, Inc.

Imara Presents Clinical Data on IMR-687 in Sickle Cell Disease at the European Hematology Association (EHA) Annual Congress

Final data from 93-patient Phase 2a clinical trial show lower annualized rate of vaso-occlusive crises (VOCs) and longer time to first VOC on IMR-687 Interim open-label extension clinical trial...
June 04, 2021 07:00 ET | Source: Imara, Inc.

Imara to Present Clinical Data on IMR-687 in Sickle Cell Disease at the European Hematology Association (EHA) Annual Congress

Oral presentation provides final results from 93-patient Phase 2a trial and additional interim data from open label extension trial Imara to host conference call and live webcast on June 11, 2021 at...
May 11, 2021 07:00 ET | Source: Imara, Inc.

Imara Reports First Quarter 2021 Financial Results and Business Highlights

On-track to report interim analyses for both Ardent sickle cell disease and Forte beta-thalassemia Phase 2b clinical trials in the second half of 2021 Completed enrollment in the...